AAV gene therapy
In this workflow, discover how to streamline your adeno-associated virus (AAV) production transition from research to the clinical scale. This infographic, which has been created by RegMedNet in association with Thermo Fisher Scientific (CA, USA), provides you with the top solutions to create a cost-effective and scalable AAV vector production system.
This infographic is part of the RegMedNet In Focus on AAV gene therapy. Discover expert opinions on this topic by visiting our feature homepage.
Illustrated by Hannah Morton (Future Science Group, London, UK).